These data indicate that PREX2 function is dispensable for early initiation and progression of BRAF-driven melanoma and do not support the existence of a melanomagenesis-relevant mutual inhibition between PTEN and PREX2 in vivo (24, 25). The gene discussed is PREX2; the disease is melanoma.